← Leaderboards
James E. Barrett
Mebias Discovery, Inc.
$4,805,544
Attributed
$9,611,087
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2018–23$5M$3.8M$2.5M$1.3M$0
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$9,611,087 · 2
By mechanism
UH3$7,453,877 · 1
UG3$2,157,210 · 1
Top collaborators
- Lawrence C Kuo8 shared
Most similar at Mebias Discovery, Inc.
Same institution · by research overlap
- Lawrence C Kuo$5,983,188
- Scott A. Reines$1,177,644
Others in their field
Other Emerging Leaders on “Novel Strategies”
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Mark Marino · Venturewell$48,913,644
- Ted Ross · University Of Georgia$39,967,158
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Xinhua Li · Nano Terra, Inc.$29,432,783
Research focus
Novel StrategiesOpioidG Protein-Coupled Receptor SignalingMu Opioid ReceptorsMediatingNovel TherapeuticsDrug DesignDrug CandidateGenerationsMorphineGtp-Binding ProteinsBeta-ArrestinAdverse EffectsMedicineAbsence Of Pain SensationConstipationAgonistDangerousnessAnalgesicsDrug DiscriminationCessation Of LifeApplications GrantsChronic PainOpioid Abuse
Grant awards (8)
Biased Mu-Opioid Receptor Analgesics to Prevent Overdose and Opioid Use Disorders$109,995
UH3 · FY2023 · DA
Biased Mu-Opioid Receptor Analgesics to Prevent Overdose and Opioid Use Disorders$1,995,232
UH3 · FY2022 · DA
Biased Mu-Opioid Receptor Analgesics to Prevent Overdose and Opioid Use Disorders$109,999
UH3 · FY2022 · DA
Biased Mu-Opioid Receptor Analgesics to Prevent Overdose and Opioid Use Disorders$94,999
UH3 · FY2022 · DA
Biased Mu-Opioid Receptor Analgesics to Prevent Overdose and Opioid Use Disorders$1,996,702
UH3 · FY2021 · DA
Biased Mu-Opioid Receptor Analgesics to Prevent Overdose and Opioid Use Disorders$3,146,950
UH3 · FY2020 · DA
Biased Mu-Opioid Receptor Analgesics to Prevent Overdose and Opioid Use Disorders$1,263,814
UG3 · FY2019 · DA
Biased Mu-Opioid Receptor Analgesics to Prevent Overdose and Opioid Use Disorders$893,396
UG3 · FY2018 · DA